Terms and Data
Intraday Chart Close
Strike163.33 Moneyness37.6% OTM
Effective Gearing* 4.1 Delta* 34%
Implied Volatility75.5% Vega2.7%
Entitlement Ratio100 Outstanding Quantity
(M Shares) / %0.5/ 0.6%
Theta-1.00% Premium (%)45.9
Maturity
(Y-M-D)2026-06-12
Break-Even (HKD)173.23
Listing 2025-09-08
Today 2026-01-14
Last Trading 2026-06-08
Maturity 2026-06-12
Last Trade Date (Y-M-DD)2026-06-08 Board Lot (Shares)10,000
Approximate Change for 1 Tick
Price Change of warrants(Sensitivity)*0.2
 
Listing 2025-09-08
Today 2026-01-14
Last Trading 2026-06-08
Maturity 2026-06-12
*Effective Gearing and Delta are derived from J.P. Morgan’s proprietary pricing model. These parameters reflect the relationship between the price of the underlying asset and the theoretical price changes of the Warrants. Investors should note that these figures are for reference only and may fluctuate with changes in the underlying asset price and the remaining time to maturity of the Warrants. In addition to the performance of the underlying asset, the Warrants price may also be affected by other market factors. For details, please refer to our educational articles and the listing documents.
Related Document
Listing Document Download Additional DocumentDownload Announcement-
Underlying
118.70
Change (%)
-1.300 (-1.1%)
  • High 122.20
  • Low 117.00
  • Turnover 953.5 (M)
Warrant Money Flow of Underlying More
Last Day
-0.21(M)
-(M)
5 Days
-0.45(M)
-(M)
  • Money In-Flow
  • Money Out-Flow
Last Updated Time : 2026-01-14 16:35   |   (Delayed*) - Minimum 15 mins delayed
  • 2026-01-13 【焦點股份】藥明康德發盈喜 預期去年全年純利按年增長約1倍至約191.5億元人民幣 藥康購 18555/購 20161
  • 2025-10-13 【焦點股】藥明系顯著受壓 藥明生物及藥明康德半日跌幅介乎8-9% 藥明購 19577 藥康購 19881
  • 2025-07-29 【業績部署】藥明康德中期盈利按年升逾95% 公司上調全年整體收入預期 藥康購 18555